Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Amikacin Sulfate

    Client Email Product

    Amikacin Sulfate

    APIs // Active Pharmaceutical Ingredients

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    15
    US DMFs Filed

    US DMFs Filed

    8
    CEP/COS Certifications

    CEP/COS Certifications

    1
    JDMFs Filed

    JDMFs Filed

    2
    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    8
    API REF. PRICE (USD / KG)
    197

    API Market Place

    27
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    34
    Europe

    Europe

    3
    Canada

    Canada

    7
    Australia

    Australia

    0

    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    20
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    114.00

    Annual Reports

    0

    FDF Market Place

    2
    EXCIPIENTS
    2
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    12

    USFDA Exclusivities

    2
    DIGITAL CONTENT

    Blog #PharmaFlow

    4

    News

    10
    REF STANDARD

    EDQM

    4

    USP

    1

    JP

    0

    Other Listed Suppliers

    1
    SERVICES

    0

    Full View ScreenFull Screen View
    Enforcement Report - Week of August 25, 2021
    Enforcement Report - Week of August 25, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

    FDA
    25 Aug 2021
    Share Share
    Morton Grove's Withdrawal of Approval of 21 Abbreviated New Drug Applications
    Morton Grove's Withdrawal of Approval of 21 Abbreviated New Drug Applications

    https://www.federalregister.gov/documents/2019/12/02/2019-25946/morton-grove-pharmaceuticals-inc-et-al-withdrawal-of-approval-of-21-abbreviated-new-drug

    FEDERALREGISTER
    02 Dec 2019
    Share Share
    Emcure schizophrenia drug recalled after contamination spotted
    Emcure schizophrenia drug recalled after contamination spotted

    https://www.fiercepharma.com/manufacturing/emcure-injected-schizophrenia-drug-recalled-after-contamination-detected

    Eric Palmer FIERCE PHARMA
    29 May 2019
    Share Share
    Heritage Pharma Issues Recall of Amikacin Sulfate & Prochlorperazine Edisylate
    Heritage Pharma Issues Recall of Amikacin Sulfate & Prochlorperazine Edisylate

    https://www.pharmacompass.com/pdf/news/heritage-pharma-issues-recall-of-amikacin-sulfate-prochlorperazine-edisylate-1559107374.pdf

    PR NEWSWIRE
    28 May 2019
    Share Share
    Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of 7 Lots of Amikacin
    Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of 7 Lots of Amikacin

    http://www.fda.gov/Safety/Recalls/ucm514656.htm

    FDA
    02 Aug 2016
    Share Share
    US FDA Enforcement Report- 1/June/2016
    US FDA Enforcement Report- 1/June/2016

    https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-1june2016-1464785216.pdf

    FDA
    31 May 2016
    Share Share
    Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Amikacin Sulfate Injection USP 1 gram/4mL (250 mg/mL) Vials Due to Glass Particulate Matter
    Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Amikacin Sulfate Injection USP 1 gram/4mL (250 mg/mL) Vials Due to Glass Particulate Matter

    http://www.fda.gov/Safety/Recalls/ucm490003.htm

    FDA
    09 Mar 2016
    Share Share
    Fresenius Kabi's Generic Amikacin sulfate (250mg) approved in US for Infections
    Fresenius Kabi's Generic Amikacin sulfate (250mg) approved in US for Infections

    FRESENIUS_AMI

    FDA
    09 Dec 2015
    Share Share
    Fresenius Kabi's Generic Amikacin sulfate (50mg) approved in US for Infections
    Fresenius Kabi's Generic Amikacin sulfate (50mg) approved in US for Infections

    fresenus_50

    FDA
    09 Dec 2015
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search